FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH
|
|
|
- CAS-Nr.
- 1572725-72-4
- Englisch Name:
- FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH
- Synonyma:
- Fmoc-GIn(Trt)-Thr(psiMe,Mepro)-OH;Fmoc-Gln(Trt)-Thr[Ψ(Me,Me)Pro]-OH;FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH;FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH_1572725-72-4;Fmoc-Gln(Trt)-Thr[Psi(Me,Me)Pro]-OH≥ 99% (HPLC);(9H-Fluoren-9-yl)MethOxy]Carbonyl Gln(Trt)-ThrPsi(Me, Me)Pro-OH;(4S,5R)-3-[(S)-2-(Fmoc-amino)-5-oxo-5-(tritylamino)pentanoyl]-2,2,5-trimethyloxazolidine-4-carboxylic Acid;(4S,5R)-3-[Nα-(9-Fluorenylmethyloxycarbonyl)-Nγ-trityl-L-glutaminyl]-2,2,5-trimethyloxazolidine-4-carboxylic acid;(4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid;(4S,5R)-3-[(2S)-2-[[fluorenemethyloxycarbonyl]amino]-1,5-dioxy-5-[(triphenylmethyl)amino]pentyl]-2,2,5-trimethyl-4-azolealkanecarboxylic acid
- CBNumber:
- CB0349552
- Summenformel:
- C46H45N3O7
- Molgewicht:
- 751.87
- MOL-Datei:
- 1572725-72-4.mol
|
FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH Eigenschaften
- Siedepunkt:
- 973.5±65.0 °C(Predicted)
- Dichte
- 1.247±0.06 g/cm3(Predicted)
- storage temp.
- Store at +2°C to +8°C.
- pka
- 3.10±0.60(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to off-white
- Major Application
- peptide synthesis
- InChIKey
- JQTGZPUCAULNOC-QZNHJORUSA-N
- SMILES
- O1[C@H](C)[C@@H](C(O)=O)N(C(=O)[C@@H](NC(OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)=O)CCC(=O)NC(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C1(C)C
FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to off-white powder
FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 86)Lieferanten
- FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH
- (4S,5R)-3-[(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-1,5-dioxo-5-[(triphenylmethyl)amino]pentyl]-2,2,5-trimethyl-4-oxazolidinecarboxylic acid
- (4S,5R)-3-[Nα-(9-Fluorenylmethyloxycarbonyl)-Nγ-trityl-L-glutaminyl]-2,2,5-trimethyloxazolidine-4-carboxylic acid
- Fmoc-Gln(Trt)-Thr[Psi(Me,Me)Pro]-OH≥ 99% (HPLC)
- Fmoc-Gln(Trt)-Thr[Ψ(Me,Me)Pro]-OH
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Gln(Trt)-ThrPsi(Me, Me)Pro-OH
- 4-Oxazolidinecarboxylic acid, 3-[(2S)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1,5-dioxo-5-[(triphenylmethyl)amino]pentyl]-2,2,5-trimethyl-, (4S,5R)-
- FMOC-GLN(TRT)-THR(PSIME,MEPRO)-OH_1572725-72-4
- (4S,5R)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-[(triphenylmethyl)carbamoyl]butanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid
- (4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid
- Fmoc-GIn(Trt)-Thr(psiMe,Mepro)-OH
- (4S,5R)-3-[(S)-2-(Fmoc-amino)-5-oxo-5-(tritylamino)pentanoyl]-2,2,5-trimethyloxazolidine-4-carboxylic Acid
- (4S,5R)-3-[(2S)-2-[[fluorenemethyloxycarbonyl]amino]-1,5-dioxy-5-[(triphenylmethyl)amino]pentyl]-2,2,5-trimethyl-4-azolealkanecarboxylic acid
- 17(4S,5R)-3-[(2S)-2-[[fluorenemethoxycarbonyl]amino]-1,5-dioxo-5-[(triphenylmethyl)amino]pentyl]-2,2,5-trimethyl-4-oxazolidinecarboxylic acid
- 1572725-72-4
- C46H45N3O7
- peptide
